Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis

Annals of the Rheumatic Diseases

Volumn 75, Issue 1, 2016, Pages 218-225

  Schelbergen, R F P ^a   De Munter, W ^a   Van Den Bosch, M H J ^a   Lafeber, F P J G ^b   Sloetjes, A ^a   Vogl, T ^c   Roth, J ^c   Van Den Berg, W B ^a   Van Der Kraan, P M ^a   Blom, A B ^a   Van Lent, P L E M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGENASE; EPITOPE; MATRIX METALLOPROTEINASE; UNCLASSIFIED DRUG; VDIPEN NEOEPITOPE; BIOLOGICAL MARKER; S100A8 PROTEIN, MOUSE; S100A9 PROTEIN, MOUSE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALGRANULIN A BLOOD LEVEL; CALGRANULIN B BLOOD LEVEL; CARTILAGE MATRIX; CHONDROGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; EXPERIMENTAL OSTEOARTHRITIS; FEMUR; HIP OSTEOARTHRITIS; HISTOPATHOLOGY; HUMAN; KNEE MENISCUS; KNEE OSTEOARTHRITIS; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SYMPTOM; SYNOVIUM; TIBIA; TISSUE REPAIR; ANIMAL; ARTICULAR CARTILAGE; BIOSYNTHESIS; C57BL MOUSE; COMPLICATION; DEFICIENCY; ENZYMOLOGY; EXPERIMENTAL ARTHRITIS; FEMALE; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOMARKERS; CALGRANULIN A; CALGRANULIN B; CARTILAGE, ARTICULAR; CHONDROGENESIS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; OSTEOARTHRITIS; OSTEOPHYTE; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 84954239011     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205480     Document Type: Article

References (35)

1. de Lange-Brokaar BJE, Ioan-Facsinay A, van Osch GJVM, et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage 2012;20:1484-99.
2. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013;21:16-21.
3. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone 2012;51:249-57.
4. Bondeson J, Blom AB, Wainwright S, et al. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010;62:647-57.
5. Ayral X, Pickering EH, Woodworth TG, et al. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis-results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 2005;13:361-7.
6. Guermazi A, Roemer FW, Hayashi D, et al. Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study. Ann Rheum Dis 2011;70:805-11.
7. Conaghan PG, D'Agostino MA, Le Bars M, et al. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis 2010;69:644-7.
8. Blom AB, van Lent PL, Libregts S, et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007;56:147-57.
9. Ehrchen JM, Sunderkotter C, Foell D, et al. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009;86:557-66.
10. Foell D, Wittkowski H, Vogl T, et al. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007;81:28-37.
11. Sunahori K, Yamamura M, Yamana J, et al. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 2006;8:R69.
12. Hammer HB, Odegard S, Syversen SW, et al. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:150-4.
13. Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994;21:733-8.
14. Schelbergen RFP, Blom AB, van den Bosch MHJ, et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis Rheum 2012;64:1477-87.
15. van Lent PLEM, Blom AB, Schelbergen RFP, et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum 2012;64:1466-76.
16. van der Kraan PM, van den Berg WB. Osteophytes: relevance and biology. Osteoarthritis Cartilage 2007;15:237-44.
17. van Beuningen HM, Glansbeek HL, van der Kraan PM, et al. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 1998;6:306-17.
18. Blaney Davidson EN, Vitters EL, van Beuningen HM, et al. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 2007;56:4065-73.
19. Blom AB, van Lent PLEM, Holthuysen AEM, et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2004;12:627-35.
20. van der Kraan PM, Vitters EL, van Beuningen HM, et al. Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. J Exp Pathol (Oxford) 1990;71:19-31.
21. Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 2007;15:1061-9.
22. de Munter W, Blom AB, Helsen MM, et al. Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis. Arthritis Res Ther 2013; 15:R178.
23. van Spil WE, Jansen NWD, Bijlsma JWJ, et al. Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage 2012;20:745-54.
24. Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage 2007;15(Suppl A):A1-56.
25. Manitz M-P, Horst B, Seeliger S, et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol 2003;23:1034-43.
26. Blaney Davidson EN, Vitters EL, van der Kraan PM, et al. Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis 2006;65: 1414-21.
27. Mort JS, Magny MC, Lee ER. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope. Biochem J 1998;335(Pt 3):491-4.
28. Zreiqat H, Belluoccio D, Smith MM, et al. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res Ther. 2010;12:R16.
29. Lories RJU, Luyten FP. Bone morphogenetic proteins in destructive and remodeling arthritis. Arthritis Res Ther. 2007;9:207.
30. van Lent PLEM, Grevers LC, Blom AB, et al. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum 2008;58:3776-87.
31. Krane SM, Inada M. Matrix metalloproteinases and bone. Bone 2008;43:7-18.
32. Stickens D, Behonick DJ, Ortega N, et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 2004;131:5883-95.
33. Bord S, Horner A, Hembry RM, et al. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development. Bone 1998;23:7-12.
34. Vos PAJM, Welsing PMJ, deGroot J, et al. Skin pentosidine in very early hip/knee osteoarthritis (CHECK) is not a strong independent predictor of radiographic progression over 5 years follow-up. Osteoarthritis Cartilage 2013;21:823-30.
35. Kinds MB, Marijnissen ACA, Vincken KL, et al. Evaluation of separate quantitative radiographic features adds to the prediction of incident radiographic osteoarthritis in individuals with recent onset of knee pain: 5-year follow-up in the CHECK cohort. Osteoarthritis Cartilage 2012;20:548-56.